secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0001140361-25-023644
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotechnology updates corporate presentation; no financial or clinical data disclosed
--------------------------------------------------------------------------------

- Filed 8-K on June 25, 2025, with updated corporate presentation as Exhibit 99.1.
- Presentation titled 'Addressing the Growing Incidence of HPV16-Related Cancers' and 'Precision Designed Science For Immunotherapy'.
- No new financial results, clinical trial data, or guidance provided in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036125023644/0001140361-25-023644-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036125023644/ef20051058_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-023644

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer